Compared with other disease areas, central nervous system (CNS) disorders have had the highest failure rate for new compounds in advanced clinical trials. Most
Improving and Accelerating Therapeutic Development for Nervous System Disorders is the summary of a workshop convened by the IOM Forum on Neuroscience and Nervo
Nervous system diseases and disorders are highly prevalent and substantially contribute to the overall disease burden. Despite significant information provided
On March 3-4, 2016, the National Academies of Sciences, Engineering, and Medicine's Forum on Neuroscience and Nervous System Disorders held a workshop in Washin
The costs associated with a drug's clinical trials are so significant that it has become necessary to validate both its safety and efficacy in animal models pri